Quince Therapeutics Inc.

11/11/2024 | Press release | Distributed by Public on 11/11/2024 21:20

Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting